Literature DB >> 22510761

Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.

Adam D Toll1, Jonathan I Epstein.   

Abstract

Typically in invasive papillary urothelial carcinoma both the overlying papillary and the invasive components are high grade. We describe a series of patients with invasive low-grade papillary urothelial carcinoma (LPUC) in which both the noninvasive and invasive components are low grade. A retrospective search from The Johns Hopkins Surgical Pathology Database and consult cases from one of the author's files from 1998 to 2011 found 54 cases of invasive LPUC, excluding the more common, unique, and already well-characterized nested variant of urothelial carcinoma. Slides were available for 41 cases and formed the basis of the current study. The mean patient age was 68.4 years, with a male predominance. The specimens consisted of 37 bladder biopsies, 1 renal pelvis biopsy, 1 cystoprostatectomy specimen, 1 nephrectomy specimen, and 1 nephroureterectomy specimen. In all cases, invasion was limited to the superficial lamina propria above the muscularis mucosae. None of the histologic features correlated with tumor recurrence. Follow-up information was available for 73% of cases, with an average time interval of 49 months. Recurrent tumor was identified in 10/29 (34%) cases; however, 34% of cases without recurrence had limited follow-up (<24 mo). Three patients showed progression in tumor grade, and 3 additional patients progressed in both grade and stage (60% stage/grade progression). Four patients developed recurrence with ureteral noninvasive LPUC (2 in the bladder and 2 in the ureter). All are alive without disease. As this lesion is being increasingly recognized, larger studies are needed to determine whether invasion arising in LPUC is a significant risk factor for future disease.

Entities:  

Mesh:

Year:  2012        PMID: 22510761     DOI: 10.1097/PAS.0b013e318253d6e0

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

Review 1.  Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Authors:  Mahul B Amin; Steven C Smith; Victor E Reuter; Jonathan I Epstein; David J Grignon; Donna E Hansel; Oscar Lin; Jesse K McKenney; Rodolfo Montironi; Gladell P Paner; Hikmat A Al-Ahmadie; Ferran Algaba; Syed Ali; Isabel Alvarado-Cabrero; Lukas Bubendorf; Liang Cheng; John C Cheville; Glen Kristiansen; Richard J Cote; Brett Delahunt; John N Eble; Elizabeth M Genega; Christian Gulmann; Arndt Hartmann; Cord Langner; Antonio Lopez-Beltran; Cristina Magi-Galluzzi; Jorda Merce; George J Netto; Esther Oliva; Priya Rao; Jae Y Ro; John R Srigley; Satish K Tickoo; Toyonori Tsuzuki; Saleem A Umar; Theo Van der Kwast; Robert H Young; Mark S Soloway
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

2.  Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder.

Authors:  Antonio Lopez Beltran; Liang Cheng; Rodolfo Montironi; Ana Blanca; Manuel Leva; Morgan Rouprêt; Jorge Fonseca; Alfredo Vidal; Carmen L Menendez; Judit Pallares; Enrico Bollito; Carlos Reymundo; Rafael J Luque; Eva Comperat
Journal:  Virchows Arch       Date:  2014-05-31       Impact factor: 4.064

Review 3.  The pathology of urinary bladder lesions with an inverted growth pattern.

Authors:  Aitao Guo; Aijun Liu; Xiaodong Teng
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

4.  Evaluation of P53 and CK20 Immunohistochemical Markers in Comparison with Morphologic Findings in Low- and High-grade Urothelial Carcinomas.

Authors:  Mahsa Ahadi; Afshin Moradi; Banafshe Bayat; Hanieh Zham; Seyed Jalil Hosseini; Sara Zahedifar; Afsoon Taghavi
Journal:  Iran J Pathol       Date:  2021-05-09

5.  Induction of apoptosis by sinulariolide from soft coral through mitochondrial-related and p38MAPK pathways on human bladder carcinoma cells.

Authors:  Choo-Aun Neoh; Robert Y-L Wang; Zhong-Hao Din; Jui-Hsin Su; Yu-Kuei Chen; Feng-Jen Tsai; Shun-Hsiang Weng; Yu-Jen Wu
Journal:  Mar Drugs       Date:  2012-12-18       Impact factor: 5.118

6.  Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells.

Authors:  Te-Chih Cheng; Zhong-Hao Din; Jui-Hsin Su; Yu-Jen Wu; Chih-I Liu
Journal:  Mar Drugs       Date:  2017-08-02       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.